Login / Signup

Long-term follow-up of anti-PD-1 naïve patients with metastatic melanoma treated with IDO/PD-L1 targeting peptide vaccine and nivolumab.

Cathrine Lund LorentzenJulie Westerlin KjeldsenEva EhrnroothMads Hald AndersenInge Marie Svane
Published in: Journal for immunotherapy of cancer (2023)
NCT03047928.
Keyphrases
  • cancer therapy
  • drug delivery